Knight Therapeutics's total assets for Q1 2025 were C$1.00B, an increase of 4.07% from the previous quarter. KHTRF total liabilities were C$207.60M for the fiscal quarter, a 23.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.